Blair William & Co. IL Lowers Position in Stryker Corporation $SYK

Key Points

• Blair William & Co. IL reduced its holdings in Stryker Corporation by 0.2%, owning 924,257 shares valued at $365.6 million, making it the 17th largest position in their portfolio.
• Insider Ronda E. Stryker sold 200,000 shares for $75.3 million, which decreased her ownership by 5.84%, while other insiders also made notable sales in August.
• Stryker Corporation achieved an earnings per share of $3.13 for the last quarter, exceeding estimates, and also declared a quarterly dividend of $0.84 per share.

Blair William & Co. IL lowered its position in shares of Stryker Corporation (NYSE:SYK - Free Report) by 0.2% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 924,257 shares of the medical technology company's stock after selling 2,118 shares during the quarter. Stryker accounts for approximately 1.0% of Blair William & Co. IL's investment portfolio, making the stock its 17th biggest holding. Blair William & Co. IL owned 0.24% of Stryker worth $365,664,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Consolidated Portfolio Review Corp lifted its position in Stryker by 4.2% in the second quarter. Consolidated Portfolio Review Corp now owns 648 shares of the medical technology company's stock valued at $256,000 after buying an additional 26 shares during the last quarter. Sunflower Bank N.A. raised its stake in shares of Stryker by 4.0% in the 2nd quarter. Sunflower Bank N.A. now owns 696 shares of the medical technology company's stock valued at $275,000 after acquiring an additional 27 shares during the period. Pitti Group Wealth Management LLC boosted its position in shares of Stryker by 3.2% during the second quarter. Pitti Group Wealth Management LLC now owns 861 shares of the medical technology company's stock worth $341,000 after buying an additional 27 shares during the period. Sachetta LLC lifted its stake in Stryker by 58.7% during the 2nd quarter. Sachetta LLC now owns 73 shares of the medical technology company's stock worth $29,000 after acquiring an additional 27 shares in the last quarter. Finally, Comprehensive Financial Consultants Institutional Inc. grew its holdings in shares of Stryker by 0.6% in the second quarter. Comprehensive Financial Consultants Institutional Inc. now owns 4,546 shares of the medical technology company's stock valued at $1,799,000 after purchasing an additional 28 shares in the last quarter. Institutional investors own 77.09% of the company's stock.

Insider Buying and Selling

In related news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the transaction, the director directly owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This represents a 5.84% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Viju Menon sold 500 shares of the firm's stock in a transaction that occurred on Monday, August 25th. The shares were sold at an average price of $390.61, for a total transaction of $195,305.00. Following the completion of the sale, the insider owned 12,511 shares in the company, valued at $4,886,921.71. The trade was a 3.84% decrease in their position. The disclosure for this sale can be found here. Company insiders own 5.90% of the company's stock.

Wall Street Analysts Forecast Growth

SYK has been the subject of a number of analyst reports. Wall Street Zen downgraded shares of Stryker from a "buy" rating to a "hold" rating in a research note on Friday, September 26th. Needham & Company LLC increased their target price on shares of Stryker from $442.00 to $448.00 and gave the company a "buy" rating in a research report on Friday, August 1st. Rothschild & Co Redburn assumed coverage on shares of Stryker in a research report on Thursday, September 18th. They set a "neutral" rating and a $420.00 target price on the stock. Weiss Ratings reiterated a "buy (b-)" rating on shares of Stryker in a research note on Wednesday. Finally, Truist Financial set a $415.00 target price on shares of Stryker and gave the company a "hold" rating in a report on Monday, August 4th. Fifteen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, Stryker presently has an average rating of "Moderate Buy" and an average price target of $430.10.

Stryker Stock Performance

Shares of SYK stock opened at $375.35 on Thursday. Stryker Corporation has a 12 month low of $329.16 and a 12 month high of $406.19. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. The firm has a market capitalization of $143.50 billion, a P/E ratio of 49.72, a P/E/G ratio of 2.66 and a beta of 0.94. The company's fifty day moving average price is $380.99 and its two-hundred day moving average price is $378.83.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.07 by $0.06. Stryker had a return on equity of 23.94% and a net margin of 12.25%.The business had revenue of $6.02 billion for the quarter, compared to analyst estimates of $5.92 billion. During the same period in the previous year, the company earned $2.81 earnings per share. The company's revenue for the quarter was up 11.1% compared to the same quarter last year. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Tuesday, September 30th will be paid a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker's dividend payout ratio (DPR) is 44.50%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.